Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Myloxifin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Myloxifin 10mg/5mg modified-release tablets
0407020AFBCAAAA
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 33 |
|
Myloxifin 20mg/10mg modified-release tablets
0407020AFBCABAB
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 21 |
|
Myloxifin 5mg/2.5mg modified-release tablets
0407020AFBCADAC
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 13 |
|
Myloxifin 40mg/20mg modified-release tablets
0407020AFBCACAD
|
Myloxifin | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | 11 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.